Latest Stock Split Details
Key information about Outlook Therapeutics, Inc.'s most recent stock split
Split Date: 2024-03-14
Split Ratio: 1:20
Price Before Split: $0.29
Price After Split: $0.01
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 20.00 times fewer shares (a 1:20 ratio)
- The price per share is increased proportionally
Historical Stock Splits
A comprehensive history of Outlook Therapeutics, Inc.'s stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2024-03-14 | 1:20 | Yes | $0.29 | $0.01 |
| 2019-03-18 | 1:8 | Yes | $0.89 | $0.11 |
About Outlook Therapeutics, Inc.
Company overview and industry information
Outlook Therapeutics, Inc. (OTLK) operates in the Biotechnology industry. The recent 1-for-20 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.
Biotechnology
Go to Outlook Therapeutics, Inc. Summary